ÖZKOCAMAN, V. Et Al. 2014. Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. 56th American Society of hematology , (San-Francisco, Costa Rica).

ÖZKOCAMAN, V., ÖZKALEMKAŞ, F., & ALİ, R., (2014). Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients . 56th American Society of hematology, San-Francisco, Costa Rica

ÖZKOCAMAN, VİLDAN, FAHİR ÖZKALEMKAŞ, And RIDVAN ALİ. "Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients," 56th American Society of hematology, San-Francisco, Costa Rica, 2014

ÖZKOCAMAN, VİLDAN Et Al. "Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients." 56th American Society of hematology , San-Francisco, Costa Rica, 2014

ÖZKOCAMAN, V. ÖZKALEMKAŞ, F. And ALİ, R. (2014) . "Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients." 56th American Society of hematology , San-Francisco, Costa Rica.

@conferencepaper{conferencepaper, author={VİLDAN ÖZKOCAMAN Et Al. }, title={Oral valganciclovir as preemptive therapy for Cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients}, congress name={56th American Society of hematology}, city={San-Francisco}, country={Costa Rica}, year={2014}}